| HOME >> MEDICINE >> TECHNOLOGY |
$ 12,852,601$ 9,845,480$ 23,799,006$ 20,077,292Cost of sales
6,493,4075,186,39612,035,68110,805,100Gross profit
6,359,1944,659,08411,763,3259,272,192Gross profit %
49.5%47.3%49.4%46.2%Costs and expenses:Marketing and selling
5,012,7472,871,6758,894,7275,648,992Research and development
251,672241,390529,527684,418General and administrative
2,403,6981,747,6044,112,7913,438,351Total operating expenses
7,668,1174,860,66913,537,0459,771,761Loss from operations
(1,308,923)(201,585)(1,773,720)(499,569)Other income (expense)Interest income
51,97749,717104,547105,373Interest expense
(123,596)(39,470)(154,855)(80,588)Other income
(12,865)(34,739)(29,147)(61,386)Net loss before income taxes
(1,393,407)(226,077)(1,853,175)(536,170)Income tax expense(benefit)
(134,009)125,339(424,695)(15,596)Net loss
$ (1,259,398)$ (351,416)$ (1,428,480)$
(520,574)Loss per common share - Basic
$
(0.10)$
(0.03)$
(0.12)$
(0.04)Loss per common share - Diluted
$
(0.10)$
(0.03)$
(0.12)$
(0.04)Weighted Average Shares:
12,223,34712,195,33412,174,78012,193,441BasicWeighted Average Shares:Diluted
12,223,34712,195,33412,174,78012,193,441Rochester Medical CorporationPress Release - F11 Second Quarter Condensed Balance Sheets(unaudited)March 31,September 30,20112010Current AssetsCash and equivalents
$ 4,889,264$
4,545,907Marketable securities
29,468,85130,967,007Accounts receivable
9,179,7687,858,540Inventories
11,867,1399,240,291Prepaid expenses and other assets
2,236,128846,899Deferred income tax
851,562872,849Total current assets
58,492,71254,331,493Property and equipment, net
11,929,96710,017,239Deferred income tax
1,195,4401,175,052Intangible assets, net
11,159,8885,580,726Goodwill10,680,5724,561,781Total Assets
$ 93,458,579$ 75,666,291Current liabil
'/>"/>
| SOURCE Rochester Medical Corporation Copyright©2010 PR Newswire. All rights reserved |